Back

Heart rate from intermittent home measurements within an atrial fibrillation screening program is associated with mortality

7 April 2024 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 4 Electrocardiography (ECG) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Miss Rachel Van Der Velden

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Post-ablation atrial arrhythmogenic channels predict atrial fibrillation recurrence - iatrogenic substrate revisited
Doctor T. Althoff (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Acute procedural characteristics and safety of pulsed field cryoablation for persistent AF: multicenter results from the first in human PARALELL trial
Professor V. Essebag (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
First-time catheter ablation outcomes for atrial fibrillation are dependent on low-voltage areas rather than paroxysmal vs. persistent classifications: a REAL-AF study
Mr A. Nguyen (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Comparison of pulsed field and radiofrequency ablation for non-paroxysmal atrial fibrillation: a propensity score-matched analysis
Doctor V. Sousonis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Quantifying local cardiac substrate heterogeneity from high density recordings: an experimental study
Mr S. Ruiperez-Campillo (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 4

The Event

Event poster

EHRA 2024

7 April 2024 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Heart rate and prognosis of heart failure with reduced ejection fraction in women and men in sinus rhythm.
thumbnail
Congress Presentation
Impact of atrial fibrillation on cardiac arrest: a nationwide cohort study
thumbnail
Congress Presentation
Screening for Atrial Fibrillation (AF) by handheld single-lead ECG and risk of all-cause mortality stratified by non-AF cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources